Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
iShares Biotechnology ETF

iShares Biotechnology ETF (IBB) Stock Overview

Explore iShares Biotechnology ETF’s financial performance, market position, analyst ratings, and future outlook.

IBB●NASDAQ
Financial ServicesAsset Management
$212.53
$1.03(0.48%)
U.S. Market opens in 9h 32m

iShares Biotechnology ETF (IBB)

Meyka AI Score

Z

Key Financials

Market Cap10.5B
P/E RatioN/A
EPS (TTM)$7.73
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$216.72
3 Months$226.98
1 Year Target$166.71

IBB Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of iShares Biotechnology ETF (NASDAQ: IBB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, iShares Biotechnology ETF's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IBB on the NASDAQ shows an RSI of 69.54, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $166.71 for the NASDAQ listing.

Key metrics behind iShares Biotechnology ETF's NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 10.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IBB on the NASDAQ.

Price Performance (NASDAQ: IBB)

1-Day Change
-0.48%
5-Day Change
1.01%
1-Month Change
12.96%
3-Month Change
25.91%
6-Month Change
20.51%
Year-to-Date (YTD) Change
25.93%
1-Year Change
55.05%
3-Year Change
67.53%
5-Year Change
23.96%
All-Time (Max) Change
516.03%

Contact Information

https://www.ishares.com/us/products/239699/ishares-biotechnology-etf
1-800-474-2737
400 Howard Street, San Francisco, CA, 94105

Company Facts

IPO DateFeb 12, 2001
CountryUS
Actively Trading

Frequently Asked Questions